The J P Morgan healthcare conference may be over bit that doesn't mean the deal making is over , often deals that took shape at the meeting materialise later in the year ,and some recent buzz puts Pfizer and Biogen and the centre of potential deals ...Pfizer is reportedly eyeing a buyout of cardiovascular player Amarin ..Meanwhile Biogen could be another player if JPM executives are any indications , " The big Biotech would love to get it's hands on something a bit larger with multiple phase 3 assets " management said, as quoted by Mizuho analyst Salim Syed who noted the company has $ 13 bill.worth of finance capacity ..That kind-of deal would invoke a change of business development strategy for Biogen which has traditionally done early stage deals ..........
The long awaited M&A boom will hit Biopharma in 2019 despite the constant worries Prognosticators predict ....As Col would state " just saying "
- Forums
- ASX - By Stock
- Stem cells ramping up..
The J P Morgan healthcare conference may be over bit that...
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
95.0¢ |
Change
-0.015(1.55%) |
Mkt cap ! $1.084B |
Open | High | Low | Value | Volume |
96.5¢ | 96.5¢ | 94.5¢ | $2.433M | 2.552M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 72431 | 94.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
95.0¢ | 20225 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 72431 | 0.945 |
6 | 52140 | 0.940 |
8 | 92185 | 0.935 |
5 | 73150 | 0.930 |
4 | 51132 | 0.925 |
Price($) | Vol. | No. |
---|---|---|
0.950 | 20225 | 5 |
0.955 | 42472 | 3 |
0.960 | 80775 | 4 |
0.965 | 57967 | 5 |
0.970 | 73641 | 5 |
Last trade - 16.10pm 27/08/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
SBW
SHEKEL BRAINWEIGH LTD
Dani Nadri, Country Manager Australia
Dani Nadri
Country Manager Australia
SPONSORED BY The Market Online